New Zealand Pharmaceuticals (NZP) and Dextra Laboratories proudly joined ICE Pharma following a successful merger which was completed in August 2020. NZP develops and manufactures biopharmaceutical products specialising in high purity bile acids, blood group products, complex carbohydrates and other pharmaceutical intermediates and APIs. Established in 1971 to extract and purify biochemicals from by-products of the New Zealand meat processing industry, NZP has evolved over its ~50 year history into a diversified developer and manufacturer of high value pharmaceutical ingredients with a global raw material procurement and end-product distribution network. Today, NZP is a valued supplier to leading global pharmaceutical manufacturers worldwide.